During lytic infection of alphaherpesviruses, viral genes are expressed in three temporally ordered tiers, designated immediate-early (IE) or a genes, early or b genes and late or c genes (Roizman & Knipe, 2001 ). The five HSV-1 a genes, a0, a4, a22, a27 and a47, encode infected-cell proteins (ICPs) 0, 4, 22, 27 and 47, respectively. ICP4 is the major regulatory protein and affects viral gene expression both positively and negatively, including its own regulation (Leopardi et al., 1995) . These HSV-1 a genes are transactivated by the structural protein VP16 (Weir, 2001) .
Pseudorabies virus (PRV) has only one IE gene (IE180), which encodes a protein of 180 kDa (IE180; Ihara et al., 1983 ). IE180 has a high level of similarity to the IE proteins of other alphaherpesviruses, such as ICP4 [herpes simplex virus type 1 (HSV-1)], IE40 [varicella-zoster virus (VZV)], IE1 (equid herpesvirus 1) and p180 (bovine herpesvirus 1) (Vlcek et al., 1989) . These proteins have been divided into five collinear regions based on their predicted amino acid sequences, with a high level of similarity in regions 2 and 4 and little similarity in regions 1, 3 and 5 (Cheung, 1989; Wu & Wilcox, 1991) . The IE180 protein has a DNA-binding domain that binds specifically to the consensus sequence of the alphaherpesviruses' transcription initiation site (Wu & Wilcox, 1991) , implying that it has a role in the negative regulation of its own gene.
The purpose of this study was firstly to construct and characterize recombinant PRV by using the HSV-1 a4-TK gene as a selection marker, and then to use the recombinants to study the role of the PRV IE180 protein in HSV-1 a4 promoter regulation and in the possible complementation of ICP4-deficient HSV-1.
Two PRV recombinants, gIS8 and N1aHTK, were constructed by insertion of the HSV-1 chimeric gene a4-TK (Post et al., 1981; Poffenberger et al., 1983) , which is included in the 3?6 kbp PvuII fragment. This fragment has the a4 gene promoter-regulatory region juxtaposed in appropriate transcriptional orientation to the HSV-1 TK gene; it is used widely for genetic manipulation of HSV-1 (Roizman & Jenkins, 1985) to supply TK activity to recombinant viruses (Post et al., 1981) . The gIS8 virus was obtained by insertion of the a4-TK gene into NcoI-NcoI sites in the PRV BamHI-7 fragment (Fig. 1a) , which also includes gI, gE and US9 (Fernández et al., 1999) . This insertion produced an increase in mobility in the PRV BamHI-7 fragment compared to that of the BamHI-6 fragment ( Fig. 1b and c, lanes 3 and 4) . The N1aHTK recombinant was made by insertion of the a4-TK gene into the BalI site at codon 264 of the PRV TK gene sequence, which is located in the BamHI-11 fragment (Fig. 1a) . a4-TK insertion produced a mobility increase in the PRV BamHI-11 fragment, compared to that of the BamHI-7 fragment (Fig. 1b and c , lanes 5 and 6).
Functional consequences of the incorporation of the a4-TK chimeric gene into gIS8 and N1aHTK recombinant viruses were studied by HSV-1 TK expression analysis. BHK (TK 2 ) cells were infected with wild-type viruses (PRV NIA 3 or HSV-1 F), the TK-deficient PRV mutant (ATK5) (Prieto et al., 1991) or the recombinant viruses (N1aHTK and gIS8). Cell extracts were then assayed for TK activity. No TK induction was seen with the TK mutant virus ATK5, but similarly high activity levels were observed for wild-type PRV and recombinants N1aHTK and gIS8 (Table 1) . One consequence of HSV-1 TK expression in the PRV recombinant viruses was a distinct sensitivity to nucleoside analogues compared to that of the wild-type PRV, which expressed its own TK activity. Herpesvirus TK enzymes show individual differences in their ability to phosphorylate nucleoside analogues (Kit, 1985) . The sensitivity of gIS8 and N1aHTK recombinant viruses to inhibition by ganciclovir (GCV) was tested in a TCDI 50 reduction assay (Table 1) . Inhibition of infection with GCV was approximately 3 logs down for the recombinant viruses and similar to that of HSV-1. In contrast, in wild-type PRV, which expresses its own TK activity (Table 1) , GCV exhibits less than 1 log inhibition. Both N1aHTK and gIS8 PRV recombinant viruses could thus be used as vaccine vectors in genetic manipulation studies, using GCV as a nonmutagenic selection factor (Godeau et al., 1992) . gIS8 is of particular interest as it is defective in glycoprotein E, which is used as a vaccine marker in the control of Aujeszky's disease (van Oirschot et al., 1990) . These PRV recombinants could also be used to generate oncolytic viruses in human gene therapy (Boldogkoi & Nogradi, 2003) . The increased GCV sensitivity compared to wildtype would confer additional biosafety in the event of replication outside tumour regions, as occurs with HSV-1 (Stanziale & Fong, 2003) .
Detection of TK activity in the recombinant viruses correlated with HSV-1 TK gene mRNA expression. By using Northern blot analysis, we studied expression of IE mRNA (a-RNA) and early mRNA (b-RNA) in recombinant viruses by using cycloheximide and phosphonoacetic acid (PAA) treatment, respectively, and late RNA in the absence of inhibitors (Fig. 1d) . Cytoplasmic RNA (Camacho & Tabarés, 1996) was fractionated on a 1 % formaldehyde agarose gel, blotted onto nitrocellulose and hybridized [according to Cistué & Tabarés (1992) ] with 32 P-labelled 0?3 kbp TK DNA corresponding to the SacI-PstI fragment, nt 447-748 of the coding sequence (McKnight, 1980) . HSV-1 TK mRNA was detected as a transcript of approximately 1?3 kbp (McKnight, 1980) . TK behaved as an early gene in HSV-1, its natural infection context, as it was expressed in the presence of PAA (Fig. 1d, lane C) and in the absence of cycloheximide or PAA (Fig. 1d, lane D) . In contrast, HSV-1 TK mRNA derived from the a4-TK chimeric gene was expressed as an IE transcript in recombinant PRVs N1aHTK and gIS8, showing overaccumulation in the presence of cycloheximide (Fig. 1d, lanes E and H) and was inhibited strongly in early or late infection phases (Fig. 1d,  lanes F, G, I and J). The HSV-1 a4 promoter thus behaves as an IE promoter in the PRV recombinant genomic context, with strong inhibition of expression in the early and late phases, implying homologous regulation of the HSV-1 promoter by PRV proteins.
Autorepression of gene expression by ICP4 involves physical interaction between the protein and DNA (Michael & Roizman, 1993) . As the ICP4 and IE180 proteins share extensive identity in the domains termed regions 2 and 4, autoregulation of HSV-1 ICP4 and PRV IE180 gene transcription may occur through a similar mechanism. Region 2 domains of both ICP4 and IE180 expressed in Escherichia coli bind to DNA sequences that overlap the transcription start site in their respective gene promoters (Wu & Wilcox, 1991) . Our results suggest that the high binding affinity observed in vitro of PRV IE180 domain 2 to the DNA sequences that flank the HSV-1 ICP4 promoter transcription start site (Wu & Wilcox, 1991) may be functional in vivo and could be implicated in negative regulation of the HSV-1 ICP4 promoter of PRV recombinants.
As autorepression of ICP4 on its own promoter is affected by binding-site orientation and its distance from the TATA box (Leopardi et al., 1995) , it was unclear whether the similarity of IE180 and ICP4 domain 2 regions and their target DNA sequences would be reflected by functional equivalence. To determine whether IE180, the unique PRV IE protein, is responsible for negative regulation of the HSV-1 a4 promoter, we performed transfection experiments in 293T cells with pRTKC, which encodes the chimeric a4-TK gene, either alone or together with a plasmid that encodes the PRV IE180 protein (pE180). As a control for positive regulation of the HSV-1 a4 promoter, we cotransfected pRTKC with pVP16, which encodes HSV-1 VP16 protein. The pE180 plasmid was constructed by insertion of the BamHI-8 fragment, which contains the PRV IE180 coding region, into pCDNA3 (Invitrogen). Plasmid pVP16 consists of an EcoRV-FokI fragment that contains the HSV-1 VP16 coding region, inserted into the vector pCDNA 3.1HisA (Invitrogen). Plasmid pRTKC was obtained by cloning the SalI-KpnI fragment from pHSV-1-TK into the SalI-KpnI site in the vector pRPE4 (Invitrogen) without the RSV promoter. pHSV-1-TK contains a4-TK in the pUC18 vector.
To ensure that all DNA, RNA and protein expression measurements could be compared directly, experiments were performed with the same transfection cultures of 293T-pRTKC cells, either alone or cotransfected with plasmid pEGFP, pE180 or pVP16. 293T cells (9610 6 ) were put in a 150 cm 2 flask 18 h before transfection and treated with 25 mM chloroquine (Sigma) in 6 ml medium, 5 min before transfection (Abad et al., 2002) . Plasmid construct (60 mg) in 3 ml 204 mM CaCl 2 was mixed with 3 ml 26 HBS (274 mM NaCl, 50 mM HEPES, 1?5 mM Na 2 HPO 4 , pH 7). Medium was changed after 8 h. DNA, RNA and IE180 and VP16 proteins were analysed at 48 h post-transfection. Cellular DNA was isolated by SDS/ proteinase treatment (Tabarés, 1987) ; RNA was isolated with the Total Isolation system (Promega). RNA synthesis from (59-CCATTCCACCACATCGCTGG-39) for the VP16 gene and GAPDH-S (59-CCACCCATGGCAAATTCC-39) and GAPDH-AS (59-TCTAGACGGCAGGTCAGG-39) for the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene as an internal control. For RT-PCR, RNA was reverse-transcribed to cDNA by using retrotranscriptase (GeneAmp Gold RNA; Applied Biosystems). PCR and RT-PCR products were analysed by 1 % agarose gel electrophoresis. RNA analysis showed that HSV-1 TK RNA increased 2?16-fold in the presence of VP16 protein [ Fig. 2a (iii) , lane 5], whereas it was inhibited in the presence of IE180 protein [ Fig. 2a (iii) , lane 4] compared to the amount of HSV-1 TK mRNA expressed by pRTKC alone [ Fig. 2a (iii), lane 3] . The amount of cellular RNA was similar in all experiments, as determined by the GADPH control [ Fig. 2b (iii-iv), lanes 1, 3, 4 and 5]. Presence of the a4-TK gene and the control GAPDH gene was determined by PCR [ Fig. 2a (i) , b (i)]; these products were characterized by hybridization [ Fig. 2a (ii), b (ii)]. DNA amplification products were characterized by sequencing and used as probes to analyse TK [ Fig. 2a (ii, iv)] and GAPDH [ Fig. 2b (ii), iv)] in transfected cell samples. IE180 and VP16 protein synthesis was detected by Western blot analysis [ Fig. 2a (v) ]. We conclude that the presence of the PRV IE180 gene product inhibits transcription of the HSV-1 TK gene by downregulating the HSV-1 a4 promoter to levels that were undetectable by the RT-PCR assay.
Our results provide the first in vivo evidence that the PRV IE180 protein can regulate the HSV-1 a4 promoter, as first postulated by the in vitro interaction between the PRV IE180 protein and the HSV-1 a4 promoter sequence (Wu & Wilcox, 1991) . PRV IE180 negative regulation of the HSV-1 a4 promoter is similar to PRV IE180 autoregulation in normal PRV infection. This may be due to the autoregulation domain, which is located between residues 454 and 1081 (Taharaguchi et al., 1994) . This result confirms the functional overlap between PRV and HSV-1, closely related viruses in which several proteins can substitute functionally for their respective homologues (Mettenleiter & Spear, 1994; Koslowski et al., 1997) . This functional homology in downregulation cannot be extended to other gene functions; however, as we have observed, PRV IE180 cannot compensate for the lack of growth of defective ICP4 mutants of HSV-1 (Fig. 2c) , whereas IE140 of VZV is able to do so (Felser et al., 1988; Disney & Everett, 1990) . 293T cells were transfected with the pIE180 plasmid and infected after 48 h with 0?01 m.o.i. of HSV-1 d120 (DeLuca et al., 1985) , G2 ICP4-deficient mutant viruses or HSV-1 strain F. Total cytopathic effect was developed with HSV-1 strain F at 72 h post-infection; no virus production or viral DNA [Fig. 2c , dots (i) 2, (i) 3] was detected at 7 days post-infection with G2 total ICP4-deletion mutant; only a small amount of viral DNA [Fig. 2c , dots (i) 4, (i) 5] was detected with the d120 terminal deletion mutant, but without virus growth, as titrated in cells expressing ICP4 protein. Studies are in progress to determine the inhibition step in the d120 mutant.
